Roche, in collaboration with KlinRisk, Inc, has received CE-mark for the first AI-based risk stratification tool for assessment of progressive decline in kidney function. This tool will be launched as ...

Roche and partner Klinrisk have picked up a CE-mark in the EU for an AI-based tool that can be used to predict renal function decline in patients with chronic kidney disease (CKD). The algorithm will ...

Kidney disease is a common, irreversible complication of diabetes. Researchers have developed an algorithm that uses genetic markers to predict whether a type 2 diabetic will develop kidney disease ...